1029 related articles for article (PubMed ID: 28085222)
1. Epithelial-mesenchymal transition in tumor metastasis.
Yeung KT; Yang J
Mol Oncol; 2017 Jan; 11(1):28-39. PubMed ID: 28085222
[TBL] [Abstract][Full Text] [Related]
2. Understanding the molecular mechanisms driving metastasis.
Massagué J; Batlle E; Gomis RR
Mol Oncol; 2017 Jan; 11(1):3-4. PubMed ID: 28085221
[No Abstract] [Full Text] [Related]
3. Epithelial-Mesenchymal Plasticity in Circulating Tumor Cells, the Precursors of Metastasis.
Burr R; Gilles C; Thompson EW; Maheswaran S
Adv Exp Med Biol; 2020; 1220():11-34. PubMed ID: 32304077
[TBL] [Abstract][Full Text] [Related]
4. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.
Kölbl AC; Jeschke U; Andergassen U
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529216
[TBL] [Abstract][Full Text] [Related]
5. Hybrid epithelial/mesenchymal phenotype(s): The 'fittest' for metastasis?
Jolly MK; Mani SA; Levine H
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):151-157. PubMed ID: 29997040
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck M; Christofori G
Curr Opin Cell Biol; 2016 Dec; 43():7-13. PubMed ID: 27371787
[TBL] [Abstract][Full Text] [Related]
7. LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Trapp EK; Majunke L; Zill B; Sommer H; Andergassen U; Koch J; Harbeck N; Mahner S; Friedl TWP; Janni W; Rack B; Alunni-Fabbroni M
Mol Oncol; 2017 Nov; 11(11):1508-1526. PubMed ID: 28700115
[TBL] [Abstract][Full Text] [Related]
8. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
12. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
[TBL] [Abstract][Full Text] [Related]
13. Emerging Biological Principles of Metastasis.
Lambert AW; Pattabiraman DR; Weinberg RA
Cell; 2017 Feb; 168(4):670-691. PubMed ID: 28187288
[TBL] [Abstract][Full Text] [Related]
14. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells.
Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F
Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917
[TBL] [Abstract][Full Text] [Related]
15. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
16. Epithelial to mesenchymal plasticity: role in cancer progression.
Raja R; Pandey A; Kumar P
Front Biosci (Landmark Ed); 2020 Jan; 25(5):838-873. PubMed ID: 31585920
[TBL] [Abstract][Full Text] [Related]
17. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z
J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746
[TBL] [Abstract][Full Text] [Related]
18. Epithelial Mesenchymal Transition in Tumor Metastasis.
Mittal V
Annu Rev Pathol; 2018 Jan; 13():395-412. PubMed ID: 29414248
[TBL] [Abstract][Full Text] [Related]
19. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
Yu M; Bardia A; Wittner BS; Stott SL; Smas ME; Ting DT; Isakoff SJ; Ciciliano JC; Wells MN; Shah AM; Concannon KF; Donaldson MC; Sequist LV; Brachtel E; Sgroi D; Baselga J; Ramaswamy S; Toner M; Haber DA; Maheswaran S
Science; 2013 Feb; 339(6119):580-4. PubMed ID: 23372014
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
